Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Androgen Antagonists × 1 year × Clear all

Status

Sponsor Class

OTHER 55 INDUSTRY 12 NETWORK 5 OTHER_GOV 1 NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Capecitabine 8 Oxaliplatin 7 Drug Therapy 7 tislelizumab 6 pembrolizumab 6 Surgical Procedures, Operative 6 Docetaxel 6 Carboplatin 6 Bevacizumab 6 Saline Solution 5 Fluorouracil 5 Cisplatin 5 Standard of Care 4 Radiosurgery 4 Nivolumab 4 Laparoscopy 4 Gemcitabine 4 Exercise 4 Epirubicin 4 Cyclophosphamide 4 Control Groups 4 pertuzumab 3 Vincristine 3 Trastuzumab 3 Rituximab 3 Radiotherapy 3 Prednisone 3 Paclitaxel 3 Observation 3 Metformin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06687421 2025-09-03

SPRINTR-REAL

Region Västerbotten

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡